Clinical Trials Browser

Terminated × Interventional × Uterine Cervical Dysplasia × Clear all

NCT06086054 2025-08-05

Effect of a Childcare Resource on Cervical Cancer Prevention

Phase NA Terminated

Uterine Cervical Dysplasia

NCT02140021 2025-07-14

Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer

Phase NA Terminated

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT04278326 2025-04-20

ORGANOIDES

Phase NA Terminated

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Vaginal Neoplasms, Papillomavirus Infections

NCT03267680 2025-04-13

IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3

Phase 2 Terminated

10 enrolled 19 charts

Uterine Cervical Dysplasia

NCT00577317 2021-06-23

Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer

Phase 3 Terminated

2 enrolled 5 charts

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Lymphedema, Vulvar Neoplasms

NCT00004261 2018-02-22

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

Phase 1 Terminated

BreastGenitourinaryGynecologicHead & NeckSarcoma

Breast Carcinoma In Situ, Breast Neoplasms, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Inflammatory Breast Neoplasms

NCT00278434 2017-11-24

Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3

Phase 1 Terminated

GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

NCT00629577 2017-02-01

SAGE

Phase 1 Terminated

GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

NCT00312286 2016-09-23

Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.

Phase 2 Terminated

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

NCT00117884 2016-08-19

Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.

Phase 2 Terminated

Uterine Cervical Dysplasia, Papillomavirus Infections

NCT01116245 2016-07-27

ADXS11-001

Phase 2 Terminated

Uterine Cervical Dysplasia

NCT00529464 2016-05-09

Spectroscopy Versus Standard Care in Cervical Cancer Patients

Phase 3 Terminated

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT00233727 2015-07-09

SAT

Phase 3 Terminated

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT00682552 2014-08-28

Evaluation of Initial High Risk Human Papillomavirus (HR-HPV) Viral Load as Predictive Marker for Cervical Intraepithelial Neoplasia Grade 1 (CIN1) Persistence

Phase NA Terminated

Uterine Cervical Dysplasia